NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer

Recruiting now · Not applicable

Conditions studied: Anal Cancer

In brief

This study investigates if circulating tumor DNA can improve the detection of early treatment failure or recurrence in localized squamous cell carcinoma of the anus (SCCA) after curative chemoradiotherapy thereby increasing the potential for cure. This will be done by comparing the standard follow-up program with ctDNA guided imaging follow-up. Secondly, the aim is to establish early interventions against late morbidities.

Key facts

Study ID
NCT05572801
Run by
Aarhus University Hospital
People needed
400
Starts
2023-08-02
Expected to finish
2031-06-01
Last updated by the study team
2024-08-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.